These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2870317

  • 1. Effect of BW12C on oxygen affinity of haemoglobin in sickle-cell disease.
    Keidan AJ, Franklin IM, White RD, Joy M, Huehns ER, Stuart J.
    Lancet; 1986 Apr 12; 1(8485):831-4. PubMed ID: 2870317
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease.
    Keidan AJ, Sowter MC, Johnson CS, Marwah SS, Stuart J.
    Clin Sci (Lond); 1989 Apr 12; 76(4):357-62. PubMed ID: 2714049
    [Abstract] [Full Text] [Related]

  • 3. Preservation of deformability (filterability) of sickle cells by BW12C during progressive deoxygenation.
    Kenny MW, Stuart J.
    Br J Haematol; 1983 Nov 12; 55(3):465-71. PubMed ID: 6639888
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sickle hemoglobin oxygen affinity-shifting strategies have unequal cerebrovascular risks.
    Hebbel RP, Hedlund BE.
    Am J Hematol; 2018 Mar 12; 93(3):321-325. PubMed ID: 29150874
    [No Abstract] [Full Text] [Related]

  • 6. The effects in volunteers of BW12C, a compound designed to left-shift the blood-oxygen saturation curve.
    Fitzharris P, McLean AE, Sparks RG, Weatherley BC, White RD, Wootton R.
    Br J Clin Pharmacol; 1985 Apr 12; 19(4):471-81. PubMed ID: 3994894
    [Abstract] [Full Text] [Related]

  • 7. Substituted benzaldehydes designed to increase the oxygen affinity of human haemoglobin and inhibit the sickling of sickle erythrocytes.
    Beddell CR, Goodford PJ, Kneen G, White RD, Wilkinson S, Wootton R.
    Br J Pharmacol; 1984 Jun 12; 82(2):397-407. PubMed ID: 6733364
    [Abstract] [Full Text] [Related]

  • 8. Tucaresol increases oxygen affinity and reduces haemolysis in subjects with sickle cell anaemia.
    Arya R, Rolan PE, Wootton R, Posner J, Bellingham AJ.
    Br J Haematol; 1996 Jun 12; 93(4):817-21. PubMed ID: 8703810
    [Abstract] [Full Text] [Related]

  • 9. New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?
    Oder E, Safo MK, Abdulmalik O, Kato GJ.
    Br J Haematol; 2016 Oct 12; 175(1):24-30. PubMed ID: 27605087
    [Abstract] [Full Text] [Related]

  • 10. Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin.
    Henry ER, Metaferia B, Li Q, Harper J, Best RB, Glass KE, Cellmer T, Dunkelberger EB, Conrey A, Thein SL, Bunn HF, Eaton WA.
    Blood; 2021 Sep 30; 138(13):1172-1181. PubMed ID: 34197597
    [Abstract] [Full Text] [Related]

  • 11. The effect of the antisickling compound GBT1118 on the permeability of red blood cells from patients with sickle cell anemia.
    Al Balushi H, Dufu K, Rees DC, Brewin JN, Hannemann A, Oksenberg D, Lu DC, Gibson JS.
    Physiol Rep; 2019 Mar 30; 7(6):e14027. PubMed ID: 30916477
    [Abstract] [Full Text] [Related]

  • 12. Protection of pig epidermis against radiation-induced damage by the infusion of BW12C.
    van den Aardweg GJ, Hopewell JW, Adams GE, Barnes DW, Sansom JM, Stratford IJ, Nethersell AB.
    Int J Radiat Biol; 1991 Apr 30; 59(4):1039-51. PubMed ID: 1674270
    [Abstract] [Full Text] [Related]

  • 13. Polymerization of sickle cell hemoglobin at arterial oxygen saturation impairs erythrocyte deformability.
    Green MA, Noguchi CT, Keidan AJ, Marwah SS, Stuart J.
    J Clin Invest; 1988 Jun 30; 81(6):1669-74. PubMed ID: 3384944
    [Abstract] [Full Text] [Related]

  • 14. Reduction in potency and reversal of left-shifting activity of BW12C with the major and minor components of chicken hemoglobin.
    Wootton R, Stammers DK, White RD.
    FEBS Lett; 1986 Dec 01; 209(1):129-33. PubMed ID: 3803572
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the binding of the anti-sickling compound, BW12C, to haemoglobin.
    Merrett M, Stammers DK, White RD, Wootton R, Kneen G.
    Biochem J; 1986 Oct 15; 239(2):387-92. PubMed ID: 3814079
    [Abstract] [Full Text] [Related]

  • 16. Effect of polymerization tendency on haematological, rheological and clinical parameters in sickle cell anaemia.
    Keidan AJ, Sowter MC, Johnson CS, Noguchi CT, Girling AJ, Stevens SM, Stuart J.
    Br J Haematol; 1989 Apr 15; 71(4):551-7. PubMed ID: 2469459
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.
    Propper DJ, Levitt NC, O'Byrne K, Braybrooke JP, Talbot DC, Ganesan TS, Thompson CH, Rajagopalan B, Littlewood TJ, Dixon RM, Harris AL.
    Br J Cancer; 2000 Jun 15; 82(11):1776-82. PubMed ID: 10839290
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
    Rab MAE, van Oirschot BA, Bos J, Merkx TH, van Wesel ACW, Abdulmalik O, Safo MK, Versluijs BA, Houwing ME, Cnossen MH, Riedl J, Schutgens REG, Pasterkamp G, Bartels M, van Beers EJ, van Wijk R.
    Am J Hematol; 2019 May 15; 94(5):575-584. PubMed ID: 30784099
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.